Although CD8+ T cells have traditionally been the central focus, CD4+ T cells are increasingly recognized for their essential and multifaceted roles in anti‐tumor immunity and ICI responses.[112, 113, 114] Linnemann et al. The gene discussed is CD8A; the disease is neoplasm.